Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.184NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.187NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.342NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.500NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.511NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.506NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.482NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.335NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.499.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.134NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.393NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.526NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBNNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.462NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.147NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.6 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.5 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.4 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.39.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.233NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.320NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.635NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.19 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.15 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used